• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24456 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     NIHR Health Technology Assessment programme Probiotics for antibiotic-associated diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes
2005     West Midlands Health Technology Assessment Collaboration (WMHTAC) Probiotics for the prevention of antibiotics associated diarrhea: a systematic review
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Probiotics in infants: clinical effectiveness, safety and guidelines
2012     New Zealand National Health Committee (NHC) Problem-solving therapy (PST) for people who present to hospital with self-harm - technology note
2009     Health Services Assessment Collaboration (HSAC) Problematic substance use in older adults: a rapid literature scan
2025     NIHR Health Technology Assessment programme Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study
2021     Penn Medicine Center for Evidence-based Practice (CEP) Procalcitonin for antimicrobial discontinuation in hospitalized adult patients
2019     Health Technology Wales (HTW) Procalcitonin point-of-care testing for initial assessment of suspected sepsis
2015     National Institute for Health and Care Excellence (NICE) Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay). NICE diagnostics guidance 18
2015     NIHR Health Technology Assessment programme Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Procalcitonin utility in hospitalized acute respiratory disease
2012     Agency for Healthcare Research and Quality (AHRQ) Procalcitonin-guided antibiotic therapy
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Procedural guidance for the systematic evaluation of biomarker tests
2006     Center for Medical Technology Assessment (CMT) Procedural justice and priority setting in practice - three cases from Swedish health care
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Procedure site bleeding complications following percutaneous coronary interventions or angioplasty: a review of clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Procedures and tools for patients at risk for creutzfeldt-jakob disease: guidelines and identification
2001     Alberta Heritage Foundation for Medical Research (AHFMR) Proceedings of the conference on Evidence Based Decision Making: How to Keep Score?
1999     Danish Institute for Health Services Research (DSI) Process of organisation and staff development in hospitals. Evaluation of the SUS project
2017     National Institute for Health and Care Excellence (NICE) Processed nerve allografts to repair peripheral nerve discontinuities. NICE interventional procedures guidance 597
2011     NIHR Health Technology Assessment programme Processes in recruitment to randomised controlled trials of medicines for children (RECRUIT): a qualitative study
2019     Adelaide Health Technology Assessment (AHTA) Processing and cryopreservation of ovarian tissue prior to or after gonadotoxic treatment to preserve fertility in females for the future
2017     Adelaide Health Technology Assessment (AHTA) Processing and cryopreservation of semen, sperm and testicular tissue prior to or after gonadotoxic treatment to preserve future fertility
2008     HAYES, Inc. ProDisc-C total cervical disc replacement (Synthes Spine Co.)
2017     Penn Medicine Center for Evidence-based Practice (CEP) Productivity and access measures for primary care
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Profile of an HTA program: the AHFMR Health Technology Assessment Unit, 2002-2003
2001     Alberta Heritage Foundation for Medical Research (AHFMR) Profore compression bandage treatment of venous leg ulcers
2011     HAYES, Inc. Progesterone for the prevention of preterm birth
2007     HAYES, Inc. Progesterone for the prevention of preterm birth
2022     The Regional Health Technology Assessment Centre (HTA-centrum) Progesterone, cerclage, pessary, or acetylsalicylic acid for prevention of preterm birth in singleton and multifetal pregnancies
2012     Agency for Healthcare Research and Quality (AHRQ) Progestogens for prevention of preterm birth
2021     NIHR Health Technology Assessment programme Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review
2018     Andalusian Health Technology Assessment Area (AETSA) Prognostic genomic tests in early breast cancer: up-date of evidence.
2021     NIHR Health Technology Assessment programme Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: the PEACOCK study
1999     The Swedish Council on Health Technology Assessment (SBU) Prognostic methods in acute coronary artery disease
2021     NIHR Health Technology Assessment programme Prognostic models of survival in patients with advanced incurable cancer: the PiPS2 observational study
2021     NIHR Health Technology Assessment programme Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study
2006     Alberta Heritage Foundation for Medical Research (AHFMR) Prognostic value of B-type natriuretic peptide for congestive heart failure
2006     Adelaide Health Technology Assessment (AHTA) Program for the distribution of free nicotine patches: a smoking cessation program
2006     Adelaide Health Technology Assessment (AHTA) Program for the treatment of locally advanced prostate cancer
2020     Malaysian Health Technology Assessment (MaHTAS) Programmatic management of latent tuberculosis infection
2012     Health Sciences Institute in Aragon (IACS) Programme activities for early detection of health problems between 0 and 14 years old. Effectiveness, safety and economic evaluation of the different alternatives in the early detection of hip dysplasia in newborns
2025     Health Sciences Institute in Aragon (IACS) Programme for the use of real world data in health technology assessment: using real-world data for health technology assessment
2024     Health Sciences Institute in Aragon (IACS) Programme for the use of real world data in health technology assessment. Potential uses for real world data in the Spanish HTA Network
2004     Andalusian Health Technology Assessment Area (AETSA) Programs for smoking cessation - non-systematic review
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Programs to manage aggressive behaviour in long-term care patients: a review of clinical-effectiveness, cost-effectiveness, and guidelines
2021     NIHR Health Services and Delivery Research programme Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT
2017     Health Quality Ontario (HQO) Prolaris cell cycle progression test for localized prostate cancer: a health technology assessment
2017     Health Quality Ontario (HQO) Prolaris cell cycle progression test for localized prostate cancer: OHTAC Recommendation
2016     HAYES, Inc. Prolaris prostate cancer prognostic test
2013     HAYES, Inc. Prolaris test for prediction of prostate cancer progression
2013     NIHR Horizon Scanning Centre (NIHR HSC) Prolonged release naltrexone and bupropion (Contrave) for the management of obesity
2008     VA Technology Assessment Program (VATAP) Prolotherapy for musculoskeletal pain
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Prolotherapy for the treatment of chronic musculoskeletal pain
2008     HAYES, Inc. Prolotherapy for treatment of joint and ligamentous conditions
2011     HAYES, Inc. Promacta (eltrombopag) tablets (GlaxoSmithKline) for chronic idiopathic thrombocytopenic purpura (ITP)
2017     HAYES, Inc. Prometheus IBD sgi Diagnostic (Prometheus Laboratories Inc.)
2016     NIHR Health Technology Assessment programme PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation
2003     Israel Center for Technology Assessment in Health Care (ICTAHC) Promoting Medical Technologies in the national list of health services: 1995-2000
1999     Health Services Utilization and Research Commission (HSURC) Promoting optimal drug prescribing in Saskatchewan
2015     University of York Promoting patient-centred care planning consultations
2002     NIHR Health Technology Assessment programme Promoting physical activity in South Asian Muslim women through 'exercise on prescription'
2000     University of York Promoting the initiation of breastfeeding
2021     Penn Medicine Center for Evidence-based Practice (CEP) Prone positioning of patients on extracorporeal membrane oxygenation (ECMO)
2002     Centre for Clinical Effectiveness (CCE) Prone positioning of patients with acute respiratory distress syndrome (ARDS)
2014     HAYES, Inc. Pronto-7 with rainbow 4D technology (Masimo Corp.) for noninvasive hemoglobin measurement
2022     National Institute for Health and Care Excellence (NICE) Prontosan for treating acute and chronic wounds. NICE medical technologies guidance 67
2009     HAYES, Inc. ProOnc TumorSourceDX miRview mets (Prometheus Laboratories; Rosetta Genomics) microRNA Analysis for Carcinoma of Unknown Primary Origin (CUP)
2017     HAYES, Inc. Propel and propel mini bioabsorbable steroid-releasing sinus implants for treatment of chronic rhinosinusitis in adults
1994     Health Council of the Netherlands Gezondheidsraad (GR) Proper use of human tissue
2015     Health Quality Ontario (HQO) Prophylactic antibiotics for individuals with Chronic Obstructive Pulmonary Disease (COPD): a rapid review
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Prophylactic antibiotics vs prophylactic G-CSF in prevention of febrile neuropenia in patients with a small cell bronchus carcinoma - primary research
2020     Malaysian Health Technology Assessment (MaHTAS) Prophylactic anticoagulation in ambulatory cancer patients
2000     Centre for Clinical Effectiveness (CCE) Prophylactic beta-adrenergic blocking agents given perioperatively for preventing post-operative cardiac adverse events
2000     Centre for Clinical Effectiveness (CCE) Prophylactic beta-adrenergic blocking agents given perioperatively for preventing post-operative cardiac adverse events
2015     The Regional Health Technology Assessment Centre (HTA-centrum) Prophylactic insertion of a gastrostomy for nutritional support in patients with head and neck cancer
2015     NIHR Health Technology Assessment programme Prophylactic intra-abdominal drains for colorectal surgery
2019     NIHR Health Technology Assessment programme Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT
2002     HAYES, Inc. Prophylactic mastectomy
2002     HAYES, Inc. Prophylactic oophorectomy
2013     HAYES, Inc. Prophylactic oophorectomy for the prevention of ovarian cancer
2019     European Network for Health Technology Assessment (EUnetHTA) Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)
1998     University of York Prophylactic removal of impacted third molars: is it justified?
2012     Belgian Health Care Knowledge Centre (KCE) Prophylactic removal of pathology-free wisdom teeth: rapid assessment
2003     Norwegian Knowledge Centre for the Health Services (NOKC) Prophylactic removal of wisdom teeth
1996     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Prophylactic sclerotherapy of oesophageal varices - primary research
1992     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Prophylaxis of infectious endocarditis - consensus conference
2010     HAYES, Inc. Propofol for moderate sedation during colonoscopy
2005     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Proposal for criteria of public coverage and prioritisation in assisted human reproduction
2002     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Proposal for the indication of PET in oncology with public coverage in Catalonia
2006     Health Council of the Netherlands Gezondheidsraad (GR) Proposals for research into health effects of electromagnetic fields (0Hz - 300 GHZ)
2021     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Proposed delay for safe surgery after COVID-19
2017     Adelaide Health Technology Assessment (AHTA) Prosigna (PAM50) for predicting breast cancer recurrence
2014     HAYES, Inc. Prosigna breast cancer prognostic gene signature assay
2015     HAYES, Inc. Prosigna Breast Cancer Prognostic Gene Signature Assay
2019     Norwegian Institute of Public Health (NIPH) Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Prosorba (R) blood filtration column
2001     Alberta Heritage Foundation for Medical Research (AHFMR) Prosorba treatment for rheumatoid arthritis
2014     NIHR Health Technology Assessment programme Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study
2021     NIHR Health Technology Assessment programme Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation